Literature DB >> 9419081

Clinical observations on coexistence of sudden hearing loss and vestibular schwannoma.

A Aslan1, G De Donato, F R Balyan, M Falcioni, A Russo, A Taibah, M Sanna.   

Abstract

It has long been recognized that sudden hearing loss (SHL) may be a harbinger of vestibular schwannoma (VS). Among 192 VS patients who underwent operation in the Gruppo Otologico, Piacenza, Italy, from April 1987 to October 1995, the charts of 14 (7.3%) cases with a history of SHL were examined. SHL was the first symptom in 8 (4.2%) patients. Eight (57.1%) of 14 VS cases with SHL anamnesis had reported recovery of their previous hearing either totally or partially before establishment of tumor diagnosis. Five (35.7%) cases had recurrent bouts of SHL. SHL was observed less frequently in cases with large tumors (>3 cm). However, the frequency of SHL in patients with small tumors did not differ from that of medium-sized tumors. Awareness about coexistence of SHL and VS, as well as concomitant use of auditory brain stem response and magnetic resonance imaging, is crucial to rule out the diagnosis of VS in a patient with SHL.

Entities:  

Mesh:

Year:  1997        PMID: 9419081     DOI: 10.1016/S0194-59989770035-4

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  3 in total

1.  Vestibular schwannoma in patients with sudden sensorineural hearing loss.

Authors:  Jong Dae Lee; Byung Don Lee; Sun Chul Hwang
Journal:  Skull Base       Date:  2011-03

2.  Management of acute idiopathic sensorineural hearing loss: a survey of UK ENT consultants.

Authors:  S J Jarvis; V Giangrande; G John; A R D Thornton
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-04       Impact factor: 2.124

3.  Sudden sensorineural hearing loss as the initial symptom in patients with acoustic neuroma.

Authors:  Mengtao Song; Dayong Wang; Jin Li; Guohui Chen; Xiaolong Zhang; Hongyang Wang; Qiuju Wang
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.